Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
N/A
18 Years
95 Years
18 Years
95 Years
Not Enrolling
Both
Actinic Keratosis
Both
Actinic Keratosis
Trial Information
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Inclusion Criteria:
- 18-95 years old
- Diagnosied with actinic keratoses.
Exclusion Criteria:
- Patients who have had Isotretinoin therapy less that 1 year prior to screening.
- Patients who have an adverse reaction to light exposure (for example photo-
exacerbated seizures).
- History of porphyria
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Actinic keratosis /incomplete therapy and reoccurence
Outcome Time Frame:
18 months
Safety Issue:
No
Principal Investigator
Maria Tsoukas, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Chicago
Authority:
United States: Institutional Review Board
Study ID:
15725A
NCT ID:
NCT00814528
Start Date:
November 2007
Completion Date:
May 2011
Related Keywords:
- Actinic Keratosis
- actinic keratosis
- skin lesions
- 5-ALA
- AK
- Blu-Light
- Keratosis
- Keratosis, Actinic
- Ichthyosis
- Keratoacanthoma
Name | Location |
|---|---|
| The University of Chicago | Chicago, Illinois 60637 |
